Ki-67 Cancer Research Results
Ki-67, Ki-67 protein: Click to Expand ⟱
| Source: |
| Type: proliferation marker |
A high Ki-67 proliferation index means many cells are dividing quickly and that the cancer is likely to grow and spread.
Markers of proliferation index (Ki-67)
• Ki-67 serves primarily as a proliferation marker: higher levels are generally indicative of aggressive disease and poorer outcomes across many cancer types.
• While Ki-67 itself is not considered a driver of tumorigenesis, its expression mirrors the high proliferative activity associated with protumoral behavior.
• It is widely used in clinical practice to aid in tumor grading, prognostication, and treatment planning.
|
Scientific Papers found: Click to Expand⟱
*BioAv↓, *AntiCan↑, *ROCK1↓, *Ki-67↓, *ICAM-1↓, *cardioP↑, *antiOx↑, *NQO1↑, *HO-1↑, *TNF-α↓, *IL22↓, *NRF2↑, *NF-kB↓, *MDA↓, *Catalase↑, *SOD↑, *GSH↑, *cognitive↑, *tau↓, *hepatoP↑, *MMP2↑, *AST↓, *ALAT↓, *P450↑, *DNAdam↓, *ROS↓, *neuroP↑, *memory↑, *Ca+2↓, *Dose↝, *Dose↑, *Dose↝, *toxicity∅, PGE2↓, CDK2↓, CDK4↓, STAT3↓, NOX↓, NOX4↓, ROS↓, *SREBP1/SREBF1↓, *FASN↓, *ACC↓,
*Inflam↓, *ROS↓, *Dose↝, *Aβ42↓, *IL1β↓, *TNF-α↓, *MDA↓, *Ach↑, *MAOA↓, *LDH↓, *AChE↓, *NRF2↑, *5HT↑, *TGF-β1↑, *IL10↑, *Ki-67↓, *PCNA↓,
*Dose↝, *Synergy↑, *Ki-67↓, *testos↓, *DHT↓, *PSA↓, *IL1β↓, *IL6↓, *AKT1↓, *TNF-α↓, *EGFR↓, *STAT3↓, *COX2/PTGS2↓,
BioAv↓, BioAv↑, GSTA1↑, P450↓, TumCCA↑, HDAC↓, P21↑, p27/CDKN1B↑, DNMT1↓, DNMT3A↓, cycD1/CCND1↑, DNAdam↑, BAX↑, Cyt‑c↑, Apoptosis↑, ROS↑, AIF↑, CDK1↑, Casp3↑, Casp8↑, Casp9↑, NRF2↑, NF-kB↓, TNF-α↓, IL1β↓, CSCs↓, CD133↓, CD44↓, ALDH↓, Nanog↓, OCT4↓, hTERT/TERT↓, MMP2↓, EMT↓, ALDH1A1↓, Wnt↓, NOTCH↓, ChemoSen↑, *Ki-67↓, *HDAC3↓, *HDAC↓,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
NOX↓, 1, NOX4↓, 1, NRF2↑, 1, ROS↓, 1, ROS↑, 1,
Cell Death(tgid=5) ⓘ
AIF↑, 1, Apoptosis↑, 1, BAX↑, 1, Casp3↑, 1, Casp8↑, 1, Casp9↑, 1, Cyt‑c↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
STAT3↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
DNMT1↓, 1, DNMT3A↓, 1, HDAC↓, 1, OCT4↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, hTERT/TERT↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK1↑, 1, CDK2↓, 1, CDK4↓, 1, cycD1/CCND1↑, 1, P21↑, 1, p27/CDKN1B↑, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
ALDH↓, 1, ALDH1A1↓, 1, CD133↓, 1, CSCs↓, 1, Nanog↓, 1, NOTCH↓, 1, Wnt↓, 1,
Migration(tgid=13) ⓘ
EMT↓, 1, MMP2↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CD44↓, 1, IL1β↓, 1, NF-kB↓, 1, PGE2↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 1, ChemoSen↑, 1, GSTA1↑, 1, P450↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
hTERT/TERT↓, 1,
Total Targets: 46
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, Catalase↑, 1, GSH↑, 1, HO-1↑, 1, MDA↓, 2, NQO1↑, 1, NRF2↑, 2, ROS↓, 2, SOD↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ACC↓, 1, ALAT↓, 1, FASN↓, 1, SREBP1/SREBF1↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
AKT1↓, 1, EGFR↓, 1, STAT3↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
HDAC↓, 1, HDAC3↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↓, 1, PCNA↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
Ki-67↓, 4,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
Ki-67↓, 4,
Migration(tgid=13) ⓘ
Ca+2↓, 1, MMP2↑, 1, ROCK1↓, 1, TGF-β1↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, ICAM-1↓, 1, IL10↑, 1, IL1β↓, 2, IL22↓, 1, IL6↓, 1, Inflam↓, 1, NF-kB↓, 1, PSA↓, 1, TNF-α↓, 3,
Synaptic & Neurotransmission(tgid=18) ⓘ
5HT↑, 1, Ach↑, 1, AChE↓, 1, MAOA↓, 1,
Protein Aggregation(tgid=19) ⓘ
Aβ42↓, 1, tau↓, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
DHT↓, 1, testos↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, Dose↑, 1, Dose↝, 4, P450↑, 1, Synergy↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 1, EGFR↓, 1, IL6↓, 1, LDH↓, 1, PSA↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, cardioP↑, 1, cognitive↑, 1, hepatoP↑, 1, memory↑, 1, neuroP↑, 1, toxicity∅, 1,
Total Targets: 62
Scientific Paper Hit Count for: Ki-67, Ki-67 protein
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:425 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page